3rd China Vaccine Forum 2011

In recent years, the biopharmaceutical industry has enjoyed a stable rising trend in China. As the fastest-growing segment, the vaccine industry is experiencing a transformation. In the first half year of 2011, the biological and biochemical manufacturing industry in China have a total sales volume of 67.717 billion RMB, with a increase of 30.35%. As such positive policies as "Biological industry 12 5 development plan" was carried out, our biological pharmaceutical industry will go into an accelerating development period. As a key segment in the biological industry, vaccine products are estimated to reach a market volume of 50-60 billion RMB. ... ...More>>

Animal Vaccine Seminar

Animal Vaccine Market Outlook:
The production capacity of Chinese animal vaccine in 2009 reached 15.8 billion mini liter, in other words, 121.4 billion doses. However, the manufacturing enterprises' average production capacity utilization rate in 2009 was 43.55%, which indicated a serious over-capacity. ... ... More>>

Who will attend?

Job Title
	31% President, CEO, GM, VP
	20%Marketing / Business Develop/ Vaccine Department Director Manager
	17% R&D/Manufacture Director
	13% Production Director, QS director, Engineers
	11% Research Officer, Senior Researchers
	8% Sales Director, Manager

They are from
	39% Bio-pharmaceutical and Research Companies
	23% Equipment, Cold chain
	10% Research Institutions
	7% Vaccine Enterprises and Agency
	6% Government Authorities
	5% CRO, CMO
	10% Others